Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The drug Caplyta, owned by Intra-Cellular Therapies, is being used to treat bipolar disorder and schizophrenia. In 2024, it brought in more than $481 million in sales.
The companies argue that the U.S. Department of Justice has failed to adequately demonstrate how, and in which regions of the country, the merger would harm competition. They are asking a federal court to throw out the case.
The motion is being advanced by religious groups and hedge funds alike, with the decision to develop a report set to be voted on at the UnitedHealth Group 2025 annual meeting.
ClearRead +Confirm, new software from Riverain Technologies that improves the clarity of conventional X-ray images, has received 510(k) clearance from the FDA.
The recipients of the fifth annual Putting Patients First grant program won for initiativers to improve education and patient care in diagnostic imaging
The chairman of ASTRO expressed concern that to fund a 1-year SGR fix, Congress took money from radiosurgery without considering the impact on cancer care